Roberta Corrêa
Roberta Corrêa is the Director of the HIV Business Unit at GSK/ViiV Healthcare, where she plays a pivotal role in advancing healthcare solutions for HIV prevention. Recently, she announced the launch of Apretude, the first long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in Brazil, which represents a significant advancement in the fight against HIV. Corrêa emphasizes the importance of increasing access to innovative treatments that can enhance adherence among populations at risk, ultimately aiming to reduce new HIV infections in the country.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 9.00 | 0.08% | +0% | 211,049,527 | 158,446 | $1,500,000 | 1,126$ |
| Totals | 1 | 211,049,527 | 158,446 | $1,500,000 | 1,126$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Roberta Corrêa is the Director of the HIV Business Unit at GSK/ViiV Healthcare and emphasizes the importance of the new injectable PrEP in Brazil.
9